Downloads

  1. Antibody Discovery & Engineering Services 2/4/2026

    The Curia Antibody Center offers a comprehensive suite of services for researchers seeking the discovery and engineering of potent and functional antibodies.

  2. Bispecific Antibodies Unleashed 2/4/2026

    Explore how leveraging expert CDMO partnerships can streamline the development process and enhance the efficacy of your bispecific antibody therapies.

  3. Leveraging The Immunological Diversity Of The Pentamice® Platform For Covid-19 Antibody Discovery 2/4/2026

    Consider this alternative immunization approach — the PentaMice platform, a collection of five wildtype mouse strains bred in-house for increased MHC class II diversity — and how we're leveraging it for COVID-19 antibody discovery.

  4. The Value Of Engaging A Single CDMO For Comprehensive Biologics Services 2/4/2026

    By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.

  5. DNA-Encoded Library Data: Unlocking Chemomic Insights For Drug Discovery 2/3/2026

    Discover how chemomic analysis unlocks full DEL datasets to reveal early SAR trends, mechanism clues, and risks to help teams make clearer, data‑driven decisions and build stronger hit‑to‑lead foundations.

  6. Drug Discovery Beyond Rule Of Five: ECCS Class 3 And 4 Strategies 2/3/2026

    Gain practical guidance for advancing bRo5 candidates through improved permeability and metabolic stability with insights on ECCS classes 3 and 4, optimized in vitro tools, and design principles.

  7. AI For NAM-Ready Drug Development: Turning Promise Into Trust 1/30/2026

    AI is naturally situated for NAMs, and its value will be maximized when it is deployed as part of a rigorously validated, evidence-based strategy.

  8. From Cyclization To The Clinic: The Rising Era Of Cyclic Peptide Therapeutics 1/28/2026

    The pharmaceutical industry is currently experiencing a golden era for cyclic peptide therapeutics.

  9. Spatial Organization Of The CAR Is Critical For CAR T Cell Function 1/27/2026

    Explore how advanced single‑cell analysis links CAR localization, cell structure, and functional behavior, offering deeper insight into CAR T cell heterogeneity and performance.

  10. Automated DNA Size Selection For Flexible NGS Workflow Integration 1/27/2026

    Gain insight into automating DNA size selection that shows how optimized bead ratios and programmable handling improve fragment recovery, consistency, and throughput.